Welcome to our dedicated page for Horizon Techn news (Ticker: HRZN), a resource for investors and traders seeking the latest updates and insights on Horizon Techn stock.
Horizon Techn (HRZN) provides venture lending and structured debt solutions to innovation-driven companies across technology, life sciences, healthcare, and related sectors. This news hub offers investors and stakeholders timely access to official updates and strategic developments.
Track all essential HRZN announcements in one location, including earnings reports, partnership agreements, and operational milestones. Our curated collection ensures you stay informed about financing initiatives, portfolio company progress, and industry leadership developments without market speculation.
Key updates cover debt financing arrangements, warrant-related activity, and sector-specific growth initiatives. Bookmark this page for efficient monitoring of Horizon Techn's strategic positioning within specialty finance markets. Regular visits provide critical insights for informed analysis of HRZN's market role and investment profile.
Horizon Technology Finance Corporation (NASDAQ: HRZN) announced its plans to release third-quarter financial results on October 26, 2021, after market close. A conference call to discuss these results is scheduled for October 27, 2021, at 9:00 a.m. ET, featuring remarks from key executives including CEO Robert D. Pomeroy, Jr. Investors can participate via phone or listen through a live webcast on the Company's website. Horizon specializes in providing secured loans to venture capital-backed companies across various sectors including technology and life sciences.
Horizon Technology Finance Corporation (NASDAQ: HRZN) reported strong performance for Q3 2021, achieving a record $141 million in loan originations, with $99 million attributed to HRZN. The portfolio ended with a committed backlog of $123 million, reflecting robust demand for venture loans. During the quarter, HRZN received $50 million in loan prepayments, boosting fee and interest income. The company closed new loan commitments totaling $91 million, with a significant pipeline of opportunities, suggesting ongoing growth potential for shareholders.
Stealth BioTherapeutics (Nasdaq: MITO) completed a $25 million long-term debt facility with Horizon Technology Finance (Nasdaq: HRZN), drawing down $15 million initially. An additional $10 million is contingent on achieving a predetermined milestone. This financing aims to support ongoing clinical trials, including a recent NDA submission for Barth syndrome under FDA review. The facility includes terms for monthly repayments over 48 months, with a potential extension for the interest-only period. Stealth has issued warrants for 13,636,364 shares to Horizon at $0.11 per share.
Horizon Technology Finance will participate in the 20th Annual Capital Link Closed-End Funds & Global ETFs Forum on October 5, 2021, at 2:00 p.m. ET. CEO Robert D. Pomeroy Jr. will join the BDCs Roundtable – Financing America's Growth panel. The conference is free and aims to offer insights from leading venture debt BDC executives. Horizon specializes in providing secured loans to venture capital-backed companies in sectors like technology and life sciences, focusing on maximizing returns from debt investments and capital appreciation.
Horizon Technology Finance Corporation (NASDAQ: HRZN) announced a $30 million venture loan facility to Dropoff, Inc., with Horizon funding $12.5 million of the initial $20 million draw. Dropoff specializes in same-day delivery services for healthcare, utilizing proprietary logistics software for optimized operations. The funding will support Dropoff's working capital and acquisitions. Horizon's President emphasized the company's commitment to supporting Dropoff's growth, as it meets critical delivery needs within the healthcare sector.
Horizon Technology Finance Corporation (NASDAQ: HRZN) announced a $15 million venture loan facility to Spineology, Inc., contributing $5 million of the initial $10 million draw. Spineology, known for its anatomy-conserving solutions for lumbar spinal fusion, plans to use the funds for general working capital. The company's technology has seen strong clinical adoption, which is expected to capture market share as it develops more offerings. Horizon aims to enhance returns through its secured loans to businesses in technology and healthcare sectors.
Horizon Technology Finance Corporation (NASDAQ: HRZN) and Trinity Capital Inc. (NASDAQ: TRIN) have provided a $40 million venture loan to Nexii Building Solutions Inc., a green construction technology firm. Horizon contributed $22.5 million and $7.5 million via a private vehicle, while Trinity added $10 million. The funding aims to support Nexii's growth and working capital needs, enhancing its sustainable building initiatives. The partnership is designed to foster innovation in construction, aligning with goals for a zero-carbon economy.
Horizon Technology Finance Corporation (NASDAQ: HRZN) announced a $15 million venture loan facility to Branded Online, Inc. (Nogin), funding $5 million of the initial $10 million draw. Nogin offers a comprehensive eCommerce platform for consumer brands in various industries, enhancing revenue and profitability through AI-driven marketing and fulfillment. Horizon's President highlighted Nogin's potential to reduce operating expenses and drive growth. The partnership aims to strengthen Nogin's position in the retail market, allowing brands to focus on innovation and customer engagement.
Embody has successfully secured $11.5 million in oversubscribed equity financing and entered into a debt financing agreement with Horizon Technology Finance Corporation (NASDAQ: HRZN) for up to $9 million. An initial $5 million has already been funded, bringing total available funds to $20.5 million. This financing will help commercialize their Tapestry Biointegrative Implant and support clinical studies. The global market for sports medicine products is projected to reach $11 billion by 2023.
Horizon Technology Finance Corporation (NASDAQ: HRZN) has declared monthly cash distributions of $0.10 per share for October, November, and December 2021, totaling $0.30 per share. This follows the company's commitment to providing returns to shareholders, having paid out $160 million in distributions since its IPO in 2010. The board reviews taxable income estimates prior to declaring these distributions. Horizon also offers a Dividend Reinvestment Plan allowing stockholders to reinvest distributions into additional shares unless they opt for cash payments.
